Cheaper favipiravir brand gets nod, to enter market at Rs 59 a pill

The product comes Pune-based Brinton Pharma; Glenmark's FabiFlu is priced at Rs 73 a tablet

After Glenmark's Fabiflu, a second favipiravir (an oral antiviral drug used in Covid-19 treatment)-based formulation got approval from the drug regulator. Pune-based Brinton Pharmaceuticals claimed that it has obtained the nod from the Drug Controller General of India (DCGI) to market its brand Faviton, 

Faviton would be priced at Rs 59 per tablet as against Rs 75 per tablet for FabiFlu. Faviton will be available in a strip of 10 tablets and 50 tablets in a box.

It will be available in 200 mg tablets. Brinton will also be exporting Faviton."Emerging favourable global clinical evidence suggests Favipiravir is an effective treatment option